BOTH — Bioethics Cashflow Statement
0.000.00%
Last trade - 00:00- $1.42m
- $1.90m
- 16
- 44
- 32
- 21
Annual cashflow statement for Bioethics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.102 | -0.119 | -0.107 | -0.093 | -0.097 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0.007 | 0.003 | 0 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.022 | 0.043 | 0.077 | 0.068 | 0.075 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.079 | -0.069 | -0.027 | -0.026 | -0.022 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.056 | 0.061 | 0.028 | 0.025 | 0.022 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.023 | -0.008 | 0 | -0 | -0 |